Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Dec 29, 16:01
2006.90 -3.05 (-0.15%)
Volume
AVERAGE VOLUME
5-Day
24,513
10-Day
16,824
30-Day
22,672
5,497
  • Prev. Close

    2009.95

  • Open Price

    2043.00

  • Bid Price (Qty.)

    2000.00 (6)

  • Offer Price (Qty.)

    2028.20 (5)

NSE Live

Dec 29, 15:44
2009.70 -0.90 (-0.04%)
Volume
AVERAGE VOLUME
5-Day
632,515
10-Day
512,992
30-Day
928,187
266,984
  • Prev. Close

    2010.60

  • Open Price

    2012.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2009.70 (452)

Financials

Balance Sheet of Glenmark Pharma (in Rs. Cr.) Mar 05 Mar 04  
  12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 23.72 11.85  
Total Share Capital 43.72 21.85  
Reserves and Surplus 242.98 213.21  
Total Reserves and Surplus 242.98 213.21  
Total Shareholders Funds 286.70 235.06  
NON-CURRENT LIABILITIES  
Long Term Borrowings 407.43 50.04  
Deferred Tax Liabilities [Net] 38.61 29.32  
Other Long Term Liabilities 0.00 0.00  
Long Term Provisions 0.00 0.00  
Total Non-Current Liabilities 446.05 79.36  
CURRENT LIABILITIES  
Short Term Borrowings 29.30 64.45  
Trade Payables 55.62 46.46  
Other Current Liabilities 13.43 15.63  
Short Term Provisions 9.71 12.80  
Total Current Liabilities 108.07 139.34  
Total Capital And Liabilities 840.82 453.77  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 171.85 102.66  
Intangible Assets 37.45 35.01  
Capital Work-In-Progress 12.91 24.50  
Other Assets 0.00 0.00  
Fixed Assets 222.21 162.16  
Non-Current Investments 26.46 29.96  
Deferred Tax Assets [Net] 2.53 2.36  
Long Term Loans And Advances 0.00 0.00  
Other Non-Current Assets 0.00 0.64  
Total Non-Current Assets 251.19 195.13  
CURRENT ASSETS  
Current Investments 0.00 0.00  
Inventories 111.06 82.16  
Trade Receivables 182.10 130.48  
Cash And Cash Equivalents 109.28 6.77  
Short Term Loans And Advances 185.99 39.20  
OtherCurrentAssets 1.20 0.03  
Total Current Assets 589.63 258.64  
Total Assets 840.82 453.77  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 0.46 5.11  
CIF VALUE OF IMPORTS  
Raw Materials 34.74 21.99  
Stores, Spares And Loose Tools 0.00 0.00  
Trade/Other Goods 0.00 0.00  
Capital Goods 8.96 7.68  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 29.52 15.57  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency 0.04 37.73  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods 129.16 48.64  
Other Earnings 0.98 0.32  
BONUS DETAILS  
Bonus Equity Share Capital 15.84 3.98  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value 0.10 0.06  
Non-Current Investments Unquoted Book Value 26.41 29.92  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value -- --  
Current Investments Unquoted Book Value -- --  
Source : Dion Global Solutions Limited

Results of Glenmark

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347